LLY - Stock held $720 support next level at $760LLY - Stock back to bouncing off $720 support level on the weekly time frame. Needs to break and hold $760 resistance level for a move towards $800 . Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial. calls above $760 look good for a move towards $800
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
12.09 USD
10.59 B USD
45.04 B USD
849.67 M
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
FIGI
BBG000BNBDC2
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Eli Lilly Stock Down 10.9% Over Past YearTop or Consolidation? Here's My Take...
It's not crystal clear — I can see the case for both. But after years of chart-watching, this doesn't quite look like a top to me:
• Lacks symmetry
• Had chances to break down, but no real follow-through
🧭 Where are we headed?
I think pressure remains, and we
Eli Lillly $LLYNYSE:LLY – Long Setup Ahead of June FOMC
Eli Lilly remains fundamentally strong, with robust growth in revenue (+45% YoY), driven by weight-loss and diabetes drugs like Mounjaro and Zepbound. Despite this, the stock saw a recent pullback after a lowered FY25 profit outlook.
Technical View:
LLY is
Can Lilly Redefine Weight Loss Market Leadership?Eli Lilly is rapidly emerging as a dominant force in the burgeoning weight loss drug market, presenting a significant challenge to incumbent leader Novo Nordisk. Lilly has demonstrated remarkable commercial success despite its key therapy, Zepbound (tirzepatide), entering the market well after Novo
Eli Lilly (LLY) Shares Fall Over 15% in MayEli Lilly (LLY) Shares Fall Over 15% in May
The share price of Eli Lilly and Company (LLY), the world’s largest pharmaceutical company, has seen a sharp shift in market sentiment:
→ From its April low to high, LLY shares rose by over 30%;
→ However, since the start of May, the LLY stock price has
LLY bullish reversal confirmed.. BUY BUY BUYLLY bully reversal is absolutely confirmed
We have the following confirmations
1) closed above 20 day EMA
2) closed above 50 day EMA
3) closed above 200 day EMA
4) RSI above 60
wait till another candle closes above 200 day EMA
Buy at 866
Stop loss @ 790
TP @ 964
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US532457AM0
ELI LILLY 2025Yield to maturity
16.90%
Maturity date
Jun 1, 2025
LLYC
ELI LILLY 15/25Yield to maturity
11.70%
Maturity date
Jun 1, 2025
XS238628644
ELI LILLY 21/43Yield to maturity
7.97%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50Yield to maturity
7.68%
Maturity date
May 15, 2050
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.57%
Maturity date
Sep 15, 2060
US532457BU1
ELI LILLY 19/59Yield to maturity
6.56%
Maturity date
Mar 15, 2059
US532457BT4
ELI LILLY 19/49Yield to maturity
6.54%
Maturity date
Mar 15, 2049
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.39%
Maturity date
Mar 1, 2045
US532457BS6
ELI LILLY 19/39Yield to maturity
6.38%
Maturity date
Mar 15, 2039
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
6.31%
Maturity date
May 15, 2047
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
6.24%
Maturity date
Feb 27, 2063
See all LLY bonds
Curated watchlists where LLY is featured.
Related stocks
Frequently Asked Questions
The current price of LLY is 713.71 USD — it has decreased by −0.21% in the past 24 hours. Watch Eli Lilly and Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Eli Lilly and Company stocks are traded under the ticker LLY.
LLY stock has fallen by −3.55% compared to the previous week, the month change is a −14.73% fall, over the last year Eli Lilly and Company has showed a −11.89% decrease.
We've gathered analysts' opinions on Eli Lilly and Company future price: according to them, LLY price has a max estimate of 1,190.00 USD and a min estimate of 675.00 USD. Watch LLY chart and read a more detailed Eli Lilly and Company stock forecast: see what analysts think of Eli Lilly and Company and suggest that you do with its stocks.
LLY stock is 1.50% volatile and has beta coefficient of 0.78. Track Eli Lilly and Company stock price on the chart and check out the list of the most volatile stocks — is Eli Lilly and Company there?
Today Eli Lilly and Company has the market capitalization of 676.41 B, it has decreased by −3.95% over the last week.
Yes, you can track Eli Lilly and Company financials in yearly and quarterly reports right on TradingView.
Eli Lilly and Company is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 3.34 USD per share, whereas the estimation was 3.26 USD resulting in a 2.51% surprise. The estimated earnings for the next quarter are 5.54 USD per share. See more details about Eli Lilly and Company earnings.
Eli Lilly and Company revenue for the last quarter amounts to 12.73 B USD, despite the estimated figure of 12.67 B USD. In the next quarter, revenue is expected to reach 14.34 B USD.
LLY net income for the last quarter is 2.76 B USD, while the quarter before that showed 4.41 B USD of net income which accounts for −37.43% change. Track more Eli Lilly and Company financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.50 USD. As of today, Dividend Yield (TTM)% is 0.76%. Tracking Eli Lilly and Company dividends might help you take more informed decisions.
Eli Lilly and Company dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 25, 2025, the company has 47 K employees. See our rating of the largest employees — is Eli Lilly and Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eli Lilly and Company EBITDA is 21.55 B USD, and current EBITDA margin is 41.75%. See more stats in Eli Lilly and Company financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eli Lilly and Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eli Lilly and Company technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eli Lilly and Company stock shows the neutral signal. See more of Eli Lilly and Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.